Penlac® (Ciclopirox) - A - Detailing from Skin Therapy Letter


Penlac® (Ciclopirox)







The data gathered from clinical trials and post-marketing reports have not shown any significant systemic side effects related to the topical application of Penlac nail lacquer. Application site reactions including erythema and site burning discomfort are generally mild and have affected 1-5% of treated patients.

There is so little systemic absorption of ciclopirox ( < 5% of applied dose) that it is of no clinical significance. There have been no associated systemic drug interactions.

Next:   Patient Selection